Banner
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 History
 Advertising
 
Learn important smoking facts.
 
Bone health resources at your fingertips.
 
Advertising
 


Industry News

Eng3 - NanoVi™ Technology for Cellular Repair and Regeneration...

Search Articles: 
  • Chugai receives Orphan Drug designation for TECENTRIQ in SCLC Chugai Pharm announced that humanized anti-PD-L1 monoclonal antibody TECENTRIQ® Intravenous Infusion 1200 mg [atezolizumab (genetical recombination)], and ROS1/TRK inhibitor entrectinib which is under development, received orphan drug designation by the Ministry of Health for treatment of SCLC.
    December 06, 2018

More...

 
Email thie page to a friend. Email This Page
to a Friend 		Print this page. Print This
Page
© 1997 - 2019 Info.Resource, Inc. All rights reserved.
Privacy Policy & Cookies . Terms of Use . About . Advertising

BritishColumbiaLifeScience.com is owned and published by Info.Resource, Inc.